Have a feature idea you'd love to see implemented?
Let us know!
BPTH Bio-Path Holdings Inc
Price (delayed)
$0.799
Market cap
$3.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$10.97
Enterprise value
$2.91M
Bio-Path is a biotechnology company developing DNAbilize®, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous infusion. Bio-Path's lead
Highlights
Bio-Path Holdings's debt has shrunk by 82% YoY and by 53% QoQ
Bio-Path Holdings's EPS has soared by 73% YoY and by 34% from the previous quarter
BPTH's equity has dropped by 155% since the previous quarter and by 128% year-on-year
The quick ratio has plunged by 90% YoY and by 87% from the previous quarter
Key stats
What are the main financial stats of BPTH
Market
Valuations
Earnings
Shares outstanding
4.31M
Market cap
$3.44M
Enterprise value
$2.91M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$10.51M
EBITDA
-$10.36M
Free cash flow
-$9.51M
Per share
Balance sheet
Liquidity
EPS
-$10.97
Free cash flow per share
-$3.15
Book value per share
-$0.28
Revenue per share
$0
TBVPS
$0.98
Total assets
$2.97M
Total liabilities
$3.68M
Debt
$26,000
Equity
-$712,000
Working capital
-$476,000
Debt to equity
-0.04
Current ratio
0.86
Quick ratio
0.17
Net debt/EBITDA
0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-321.7%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BPTH stock price
How has the Bio-Path Holdings stock price performed over time
Intraday
1.43%
1 week
-11.22%
1 month
-25.33%
1 year
-92.01%
YTD
-91.37%
QTD
-12.19%
Financial performance
How have Bio-Path Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$12.4M
Net income
-$10.51M
Gross margin
N/A
Net margin
N/A
BPTH's net income is up by 37% year-on-year and by 9% since the previous quarter
The operating income is up by 26% year-on-year and by 4.9% since the previous quarter
Growth
What is Bio-Path Holdings's growth rate over time
Valuation
What is Bio-Path Holdings stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Bio-Path Holdings's EPS has soared by 73% YoY and by 34% from the previous quarter
BPTH's equity has dropped by 155% since the previous quarter and by 128% year-on-year
Efficiency
How efficient is Bio-Path Holdings business performance
BPTH's return on assets has dropped by 86% year-on-year and by 4.9% since the previous quarter
Dividends
What is BPTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BPTH.
Financial health
How did Bio-Path Holdings financials performed over time
The total assets is 19% less than the total liabilities
The quick ratio has plunged by 90% YoY and by 87% from the previous quarter
The company's current ratio has shrunk by 76% YoY and by 49% QoQ
Bio-Path Holdings's debt is 104% higher than its equity
The company's debt to equity has shrunk by 200% QoQ and by 167% YoY
BPTH's equity has dropped by 155% since the previous quarter and by 128% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.